VX-135 - J&J, Vertex
Credit Suisse Group AG Healthcare Conference (Vertex) - Dec 14, 2012 - Anticipated initiation of 12 week, once-a-day, combination therapy trial (VX-135 + GSK-805) in HCV in early 2013. 
Anticipated new trial
http://investors.vrtx.com/events.cfm
 
Dec 14, 2012
 
.